Back to Steward Partners Investment Advisory, LLC Steward Partners Investment Advisory, LLC

BCLIBCLI
5 quarters

Position history for Steward Partners Investment Advisory, LLCSteward Partners Investment Advisory, LLC's holdings in BrainStorm Cell Therapeutics In

No. Steward Partners Investment Advisory exited its BCLI (BrainStorm Cell Therapeutics in) position in Q4 2025. Its Q3 2025 13F listed 113 shares worth $80. Steward Partners Investment Advisory first reported BCLI in Q4 2024 and held it in 4 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$257

Total Shares Change

-113

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$0.56
0
2025-Q3
Unchanged
113
0.0%
$800.0%$0.70
0
2025-Q2
Unchanged
113
0.0%
$1270.0%$1.06
0
2025-Q1
Unchanged
113
0.0%
$1420.0%$1.19
0
2024-Q4
New
113
-
$2570.0%$2.37
17

Other major holders of BCLI: VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used